Abstract
One out of three stroke-patients develop language processing impairment known as aphasia. The need for ecological validity of the existing diagnostic tools motivates research on biomarkers, such as stimulus-evoked brain responses. With the aim of enhancing the physiological interpretation of the latter, we used EEG to investigate how functional brain network patterns associated with the neural response to natural speech are affected in persons with post-stroke chronic aphasia.
EEG was recorded from 24 healthy controls and 40 persons with aphasia while they listened to a story. Stimulus-evoked brain responses at all scalp regions were measured as neural envelope tracking in the delta (0.5-4 Hz), theta (4-8 Hz) and low-gamma bands (30-49 Hz) using mutual information. Functional connectivity between neural-tracking signals was measured, and the Network-Based Statistics toolbox was used to: 1) assess the added value of the neural tracking vs EEG time series, 2) test between-group differences and 3) investigate any association with language performance in aphasia. Graph theory was also used to investigate topological alterations in aphasia.
Functional connectivity was higher when assessed from neural tracking compared to EEG time series. Persons with aphasia showed weaker low-gamma-band left-hemispheric connectivity, and graph theory-based results showed a greater network segregation and higher region-specific node strength. Aphasia also exhibited a correlation between delta-band connectivity within the left pre-frontal region and language performance.
We demonstrated the added value of neural tracking when investigating functional brain networks associated with natural speech processing in post-stroke aphasia. Its higher sensitivity to language-related brain circuits favours its use as informative biomarker for the assessment of aphasia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the Research Foundation Flanders (FWO, PhD grant P.D.C. 1S40122N, grant G0D8520N), the Luxembourg National Research Fund (FNR, AFR-PhD grant J.K. 13513810) and the European Research Council (ERC) under the European Union Horizon 2020 research and innovation programme (T.F., No. 637424).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Medical Ethical Committee UZ/KU Leuven (S60007) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵Ω shared senior authorship
Data Availability
Raw EEG data can be made available upon reasonable request to the authors by qualified researchers and if the GDPR-related conditions are met
